Simon Fischer

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 10

Top Venues

Biotechnology and bioengineering

Biotechnology progress

Biotechnology journal

Boehringer Ingelheim Pharma GmbH and Co KG Biberach

Institute of Applied Biotechnology (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Boehringer Ingelheim Pharma GmbH and Co KG Biberach Aug 01 2015

Germany

Scientist :: Global Bioprocess & Pharmaceutical Development

Education History

Institute of Applied Biotechnology Dec 01 2011 - Mar 31 2015

Germany

PHD

University of Applied Sciences Albstadt-Sigmaringen Mar 01 2010 - Nov 30 2011

Germany

MSC :: Biomedical Engineering

Novartis Institutes for BioMedical Research Mar 01 2011 - Nov 01 2011

Switzerland

MSC :: Novartis Biologics Center

University of Applied Sciences Biberach Oct 01 2006 - Feb 28 2010

Germany

BSC :: Pharmaceutical Biotechnology

Publications

Howard R G Clarke, Anke Mayer-Bartschmid, Chenxing Zheng, Elizabeth Masterjohn, Falguni Patel, Mark Moffat, Qingxiang Wei, Ren Liu, Robyn Emmins, Simon Fischer, Stephanie Rieder, Thomas Kelly
When will we have a clone? An industry perspective on the typical CLD timeline. Biotechnology progress 40 (4) (2024)
Melanie Maier, Stefan Schneider, Linus Weiss, Simon Fischer, Daniel Lakatos, Joey Studts, Matthias Franzreb
Tailoring polishing steps for effective removal of polysorbate-degrading host cell proteins in antibody purification. Biotechnology and bioengineering (2024)
Howard R G Clarke, Anke Mayer-Bartschmid, Chenxing Zheng, Elizabeth Masterjohn, Falguni Patel, Mark Moffat, Qingxiang Wei, Ren Liu, Robyn Emmins, Simon Fischer, Stephanie Rieder, Thomas Kelly
When will we have a clone? An industry perspective on the typical CLD timeline. Biotechnology progress (2024)
Linus Weiß, Valerie Schmieder-Todtenhaupt, Frank Haemmerling, Daniel Lakatos, Patrick Schulz, Simon Fischer
Multi-lipase gene knockdown in Chinese hamster ovary cells using artificial microRNAs to reduce host cell protein mediated polysorbate degradation. Biotechnology and bioengineering (2023)
Daniel Komuczki, Anna Stadermann, Maximilian Bentele, Andreas Unsoeld, Johannes Grillari, Markus M Mueller, Albert Paul, Simon Fischer
High cysteine concentrations in cell culture media lead to oxidative stress and reduced bioprocess performance of recombinant CHO cells. Biotechnology journal 17 (11) (2022)
Simon Fischer, Sven Mathias, Anna Stadermann, Shumin Yang, Valerie Schmieder, Nikolas Zeh, Nicoletta Schmidt, Patrick Richter, Sara Wright, Eike Zimmermann, Yan Ley, Julia van der Meer, Thomas Hartsch, Christian Bernloehr, Kerstin Otte, Harald Bradl, Martin Gamer, Patrick Schulz
Loss of a newly discovered microRNA in Chinese hamster ovary cells leads to upregulation of N-glycolylneuraminic acid sialylation on monoclonal antibodies. Biotechnology and bioengineering 119 (3) (2022)
Sven Mathias, Anna Wippermann, Nadja Raab, Nikolas Zeh, René Handrick, Ingo H Gorr, Patrick Schulz, Simon Fischer, Martin Gamer, Kerstin Otte
Unraveling what makes a monoclonal antibody difficult-to-express: From intracellular accumulation to incomplete folding and degradation via ERAD. Biotechnology and bioengineering 117 (1) (2019)
Benjamin L Weis, Nadine Guth, Simon Fischer, Silke Wissing, Simon Fradin, Karl-Heinz Holzmann, René Handrick, Kerstin Otte
Stable miRNA overexpression in human CAP cells: Engineering alternative production systems for advanced manufacturing of biologics using miR-136 and miR-3074. Biotechnology and bioengineering 115 (8) (2018)
Melanie Schoellhorn, Simon Fischer, Andreas Wagner, René Handrick, Kerstin Otte
miR-143 targets MAPK7 in CHO cells and induces a hyperproductive phenotype to enhance production of difficult-to-express proteins. Biotechnology progress 33 (4) (2017)
Simon Fischer, Kim F Marquart, Lisa A Pieper, Juergen Fieder, Martin Gamer, Ingo Gorr, Patrick Schulz, Harald Bradl
miRNA engineering of CHO cells facilitates production of difficult-to-express proteins and increases success in cell line development. Biotechnology and bioengineering 114 (7) (2017)

Simon Fischer.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Simon Fischer